[Technique and methods in uterine leiomyoma embolization]

Radiologe. 2003 Aug;43(8):634-40. doi: 10.1007/s00117-003-0933-4.
[Article in German]

Abstract

Objective: Uterine leiomyomas are the most common benign tumors of the female urogenital tract. Beside the classic surgical treatment options the minimal-invasive embolization therapy of the leiomyomas increasingly gains importance world-wide. Technique, complications, and results of uterine leiomyoma embolization will be presented.

Methods: After careful evaluation of indications for embolization the procedure is mostly performed under conscious sedation. A single-sided femoral access route together with cross-over technique generally allows for a flow-directed embolization via both uterine arteries. After embolizing the vessels supplying the tumor, the uterine arteries should be still patent.

Results: The success rate of embolization of uterine leiomyomas ranges between 85 and 100%, whereas a reduction in size of the tumors in 42 to 83% and a relief of symptoms in up to 96% can be achieved. The total complication rate is about 10% with mainly "minor complications". Worldwide only three deaths following embolization of uterine leiomyomas were reported.

Conclusion: The high technical and clinical success rate together with a low complication rate make the embolization of uterine leiomyomas a minimally-invasive alternative to the classic treatment. As long term results are not available indication to embolization of uterine leiomyomas must be carefully established in consensus with gynecologists.

Publication types

  • Comparative Study
  • English Abstract
  • Review

MeSH terms

  • Adult
  • Embolization, Therapeutic* / adverse effects
  • Embolization, Therapeutic* / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Leiomyoma / blood supply
  • Leiomyoma / diagnosis
  • Leiomyoma / therapy*
  • Magnetic Resonance Imaging
  • Microspheres
  • Pregnancy
  • Time Factors
  • Uterine Neoplasms / blood supply
  • Uterine Neoplasms / diagnosis
  • Uterine Neoplasms / therapy*